Kaleo, maker of $4,100 overdose antidote, authorizes a generic version for just $178

The drug maker Kaleo was charging $4,100 for a two-pack of an opioid overdose reversal device. After an outcry, it’s authorizing a generic for a fraction of the price.
The auto-injector Evzio Source: Cliff Owen/AP

WASHINGTON — A month after the drug maker Kaleo came under fire from lawmakers and public-health advocates for charging $4,100 for a device that reverses overdoses, the company has announced it will introduce a generic version for a small fraction of the price.

The company announced Wednesday it has authorized its subsidiary IJ Therapeutics to produce

You're reading a preview, sign up to read more.

More from STAT

STAT7 min read
Inhumane Or Unavoidable? As Congress Scrutinizes An Increase In Monkey Research, Scientists Defend Its Necessity
Scientists are relying on monkey research more than ever before. And now Congress wants the NIH and FDA to explain why.
STAT6 min readSociety
Opinion: Combatting Misinformation On Biosimilars And Preparing The Market For Them Can Save The U.S. Billions
For more than a decade, biosimilars have flourished in Europe. That hasn't happened in the U.S. because of misinformation and poor market preparation.
STAT3 min readPolitics
With Eyes On Gilead, Lawmakers Want Details On How HHS Reviews Possible Patent Infringement
After a ruckus over a pricey Gilead Sciences drug for HIV, lawmakers want details on how HHS reviews possible patent infringement.